International Journal of Clinical Pharmacy

, Volume 39, Issue 6, pp 1228–1236 | Cite as

Pharmacist intervention acceptance for the reduction of potentially inappropriate drug prescribing in acute psychiatry

  • Sophia Hannou
  • Pierre Voirol
  • André Pannatier
  • Marie-Laure Weibel
  • Farshid Sadeghipour
  • Armin von Gunten
  • Jean-Frédéric Mall
  • Isabella De Giorgi Salamun
Research Article
  • 262 Downloads

Abstract

Background Prescribing for the elderly is challenging. A previous observational study conducted in our geriatric psychiatry admission unit (GPAU) using STOPP/START criteria showed a high number of potentially inappropriate drug prescriptions (PIDPs). A clinical pharmacist was added to our GPAU as a strategy to reduce PIDPs. Objective The objective of the present study was to assess the impact of a clinical pharmacist on PIDPs by measuring acceptance rates of pharmacist interventions (PhIs). Setting This study was conducted at the GPAU of Lausanne University Hospital. Method The clinical pharmacist attended four GPAU meetings weekly. Complete medication reviews were performed daily. The clinical pharmacist conducted standard analyses based on clinical judgment and STOPP/START criteria assessment. A PhI was generated when a PIDP was detected. When a PhI was accepted, the PIDP was considered as eliminated. Acceptance rate of PhI was calculated (number of PhI accepted/total number of PhI). Main outcome measure PhIs acceptance rates. Results In a cohort of 102 patients seen between July 2013 and February 2014, a total of 697 PhIs (average 6.8/patient) were made based on standard evaluation (n = 479) and STOPP/START criteria (n = 243). The global acceptance rate was 68% (standard, 78%; STOPP/START, 47%). Conclusion Good PhIs acceptance rates demonstrated that a clinical pharmacist can reduce PIDPs in a GPAU. PhIs based on standard evaluation had a higher acceptance than those based on STOPP/START criteria, probably because they are better adapted to individual patients. However, these two evaluation approaches can be used in a complementary manner.

Keywords

Clinical pharmacist Potentially inappropriate drug prescribing Prescribing Psychogeriatry STOPP and START criteria Switzerland 

Notes

Acknowledgements

We are thankful to Gholamrezaee Mohammad Mehdi for providing statisticical support. We are also grateful to the psychiatric, geriatric, and nursing staff of the GPAU of Lausanne University Hospital, who cooperated closely with the clinical pharmacist for this study.

Funding

This study was supported by a research award from the Swiss Association of Public Health Administration and Hospital Pharmacists (project year 2012).

Conflicts of interest

Isabella De Giorgi Salamun, Sophia Hannou, Jean-Frédéric Mall, André Pannatier, Farshid Sadeghipour, Pierre Voirol, Armin von Gunten, and Marie-Laure Weibel Borlat declare that they have no conflicts of interest.

Supplementary material

11096_2017_513_MOESM1_ESM.pdf (67 kb)
Supplementary material 1 (PDF 66 kb)
11096_2017_513_MOESM2_ESM.pdf (81 kb)
Supplementary material 2 (PDF 80 kb)

References

  1. 1.
    Dalleur O, Spinewine A, Henrard S, Losseau C, Speybroeck N, Boland B. Inappropriate prescribing and related hospital admissions in frail older persons according to the STOPP and START criteria. Drugs Aging. 2012;29(10):829–37.CrossRefPubMedGoogle Scholar
  2. 2.
    Dormann H, Sonst A, Muller F, Vogler R, Patapovas A, Pfistermeister B, et al. Adverse drug events in older patients admitted as an emergency: the role of potentially inappropriate medication in elderly people (PRISCUS). Dtsch Arztebl Int. 2013;110(13):213–9.PubMedPubMedCentralGoogle Scholar
  3. 3.
    Reich O, Rosemann T, Rapold R, Blozik E, Senn O. Potentially inappropriate medication use in older patients in Swiss managed care plans: prevalence, determinants and association with hospitalization. PLoS ONE. 2014;9(8):e105425.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    O’Connor MN, Gallagher P, O’Mahony D. Inappropriate prescribing: criteria, detection and prevention. Drugs Aging. 2012;29(6):437–52.CrossRefPubMedGoogle Scholar
  5. 5.
    Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC. Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med. 1991;151(9):1825–32.CrossRefPubMedGoogle Scholar
  6. 6.
    Laroche ML, Bouthier F, Merle L, Charmes JP. Médicaments potentiellement inappropriés aux personnes agées: intérêt d’une liste adaptée à la pratique médicale française. [Potentially inappropriate medications in the elderly: a list adapted to French medical practice]. Rev Med Intern. 2009;30(7):592–601.CrossRefGoogle Scholar
  7. 7.
    O’Mahony D, Gallagher PF. Inappropriate prescribing in the older population: need for new criteria. Age Ageing. 2008;37(2):138–41.CrossRefPubMedGoogle Scholar
  8. 8.
    Holt S, Schmiedl S, Thurmann PA. Potentially inappropriate medications in the elderly: the PRISCUS list. Dtsch Arztebl Int. 2010;107(31–32):543–51.PubMedPubMedCentralGoogle Scholar
  9. 9.
    Dimitrow MS, Airaksinen MS, Kivela SL, Lyles A, Leikola SN. Comparison of prescribing criteria to evaluate the appropriateness of drug treatment in individuals aged 65 and older: a systematic review. J Am Geriatr Soc. 2011;59(8):1521–30.CrossRefPubMedGoogle Scholar
  10. 10.
    Chang CB, Chan DC. Comparison of published explicit criteria for potentially inappropriate medications in older adults. Drugs Aging. 2010;27(12):947–57.CrossRefPubMedGoogle Scholar
  11. 11.
    Hannou S, Rousseau A, Rybarczyk-Vigouret MC, Michel B. Medication in nursing homes in Alsace: a preferential list of drugs obtained by consensus. Springerplus. 2014;3:413.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatrics Society updated beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012;60(4):616–31.Google Scholar
  13. 13.
    Hanlon JT, Schmader KE, Samsa GP, Weinberger M, Uttech KM, Lewis IK, et al. A method for assessing drug therapy appropriateness. J Clin Epidemiol. 1992;45(10):1045–51.CrossRefPubMedGoogle Scholar
  14. 14.
    Gallagher P, Ryan C, Byrne S, Kennedy J, O’Mahony D. STOPP (Screening Tool of Older Person’s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther. 2008;46(2):72–83.CrossRefPubMedGoogle Scholar
  15. 15.
    Lao CK, Ho SC, Chan KK, Tou CF, Tong HH, Chan A. Potentially inappropriate prescribing and drug-drug interactions among elderly Chinese nursing home residents in Macao. Int J Clin Pharm. 2013;35(5):805–12.CrossRefPubMedGoogle Scholar
  16. 16.
    Frankenthal D, Lerman Y, Kalendaryev E, Lerman Y. Potentially inappropriate prescribing among older residents in a geriatric hospital in Israel. Int J Clin Pharm. 2013;35(5):677–82.CrossRefPubMedGoogle Scholar
  17. 17.
    Delgado Silveira E, Alvarez Diaz A, Perez Menendez-Conde C, Munoz Garcia M, Cruz-Jentoft A, Bermejo Vicedo T. Resultados de la integracion de la atencion farmaceutica en una Unidad de Agudos de Geriatria. [Results of integrating pharmaceutical care in an Acute Geriatric Unit]. Rev Esp Geriatr Gerontol. 2012;47(2):49–54.CrossRefPubMedGoogle Scholar
  18. 18.
    Lam MP, Cheung BM. The use of STOPP/START criteria as a screening tool for assessing the appropriateness of medications in the elderly population. Expert Rev Clin Pharmacol. 2012;5(2):187–97.CrossRefPubMedGoogle Scholar
  19. 19.
    Hamilton H, Gallagher P, Ryan C, Byrne S, O’Mahony D. Potentially inappropriate medications defined by STOPP criteria and the risk of adverse drug events in older hospitalized patients. Arch Intern Med. 2011;171(11):1013–9.CrossRefPubMedGoogle Scholar
  20. 20.
    ESCP international workshop. Improving patient care through collaborative practice, 30–31 May 2013, Edinburgh, Scotland. Int J Clin Pharm. 2013;35(5):856–65.CrossRefGoogle Scholar
  21. 21.
    Lang PO, Hasso Y, Belmin J, Payot I, Baeyens JP, Vogt-Ferrier N, et al. STOPP-START: adaptation en langue francaise d’un outil de detection de la prescription médicamenteuse inappropriée chez la personne agée. [STOPP-START: adaptation of a French language screening tool for detecting inappropriate prescriptions in older people]. Can J Public Health. 2009;100(6):426–31.PubMedGoogle Scholar
  22. 22.
    Kaur S, Mitchell G, Vitetta L, Roberts MS. Interventions that can reduce inappropriate prescribing in the elderly: a systematic review. Drugs Aging. 2009;26(12):1013–28.CrossRefPubMedGoogle Scholar
  23. 23.
    Forsetlund L, Eike MC, Gjerberg E, Vist GE. Effect of interventions to reduce potentially inappropriate use of drugs in nursing homes: a systematic review of randomised controlled trials. BMC Geriatr. 2011;11:16.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Topinkova E, Baeyens JP, Michel JP, Lang PO. Evidence-based strategies for the optimization of pharmacotherapy in older people. Drugs Aging. 2012;29(6):477–94.CrossRefPubMedGoogle Scholar
  25. 25.
    Spinewine A, Fialova D, Byrne S. The role of the pharmacist in optimizing pharmacotherapy in older people. Drugs Aging. 2012;29(6):495–510.CrossRefPubMedGoogle Scholar
  26. 26.
    Gillespie U, Alassaad A, Hammarlund-Udenaes M, Morlin C, Henrohn D, Bertilsson M, et al. Effects of pharmacists’ interventions on appropriateness of prescribing and evaluation of the instruments’ (MAI, STOPP and STARTs’) ability to predict hospitalization–analyses from a randomized controlled trial. PLoS ONE. 2013;8(5):e62401.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Petrovic M, van der Cammen T, Onder G. Adverse drug reactions in older people: detection and prevention. Drugs Aging. 2012;29(6):453–62.CrossRefPubMedGoogle Scholar
  28. 28.
    Maes KA, Tremp RM, pharmacy GWgoc, Hersberger KE, Lampert ML. Demonstrating the clinical pharmacist’s activity: validation of an intervention oriented classification system. Int J Clin Pharm. 2015;37(6):1162–71.CrossRefPubMedGoogle Scholar
  29. 29.
    Gheewala PA, Peterson GM, Curtain CM, Nishtala PS, Hannan PJ, Castelino RL. Impact of the pharmacist medication review services on drug-related problems and potentially inappropriate prescribing of renally cleared medications in residents of aged care facilities. Drugs Aging. 2014;31(11):825–35.CrossRefPubMedGoogle Scholar
  30. 30.
    O’Sullivan D, O’Mahony D, O’Connor MN, Gallagher P, Cullinan S, O’Sullivan R, et al. The impact of a structured pharmacist intervention on the appropriateness of prescribing in older hospitalized patients. Drugs Aging. 2014;31(6):471–81.CrossRefPubMedGoogle Scholar
  31. 31.
    Somers A, Robays H, De Paepe P, Van Maele G, Perehudoff K, Petrovic M. Evaluation of clinical pharmacist recommendations in the geriatric ward of a Belgian university hospital. Clin Interv Aging. 2013;8:703–9.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    van Dijk KN, van Asselt DZ, Vogel D, van der Hooft CS, Van Roon EN, Brouwers JR. Interventies na een gestructureerde medicatie-analyse door klinisch geriater en ziekenhuisapotheker bij klinisch opgenomen kwetsbare oudere patienten. [Effects of a structured medication review by geriatrician and clinical pharmacologist on appropriateness of pharmacotherapy in frail elderly inpatients]. Tijdschr Gerontol Geriatr. 2009;40(2):72–8.PubMedGoogle Scholar
  33. 33.
    Tromp AM, Pluijm SM, Smit JH, Deeg DJ, Bouter LM, Lips P. Fall-risk screening test: a prospective study on predictors for falls in community-dwelling elderly. J Clin Epidemiol. 2001;54(8):837–44.CrossRefPubMedGoogle Scholar
  34. 34.
    Pathy MS, Bayer AJ, Stoker MJ. A double-blind comparison of chlormethiazole and temazepam in elderly patients with sleep disturbances. Acta Psychiatr Scand Suppl. 1986;329:99–103.CrossRefPubMedGoogle Scholar
  35. 35.
    Caspari D, Wappler M, Bellaire W. Zur Behandlung des Delirium tremens–ein Vergleich zwischen Clomethiazol und Clorazepat hinsichtlich Effektivitat und Nebenwirkungsrate. [Treatment of delirium tremens–a comparison between clomethiazole and clorazepate with reference to effectiveness and rate of side effects]. Psychiatr Prax. 1992;19(1):23–7.PubMedGoogle Scholar
  36. 36.
    Hannan MT, Gagnon MM, Aneja J, Jones RN, Cupples LA, Lipsitz LA, et al. Optimizing the tracking of falls in studies of older participants: comparison of quarterly telephone recall with monthly falls calendars in the MOBILIZE Boston Study. Am J Epidemiol. 2010;171(9):1031–6.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Zieschang T, Schwenk M, Becker C, Oster P, Hauer K. Feasibility and accuracy of fall reports in persons with dementia: a prospective observational study. Int Psychogeriatr. 2012;24(4):587–98.CrossRefPubMedGoogle Scholar
  38. 38.
    Hale WA, Delaney MJ, Cable T. Accuracy of patient recall and chart documentation of falls. J Am Board Fam Pract. 1993;6(3):239–42.PubMedGoogle Scholar
  39. 39.
    Rongen S, Kramers C, O’Mahony D, Feuth TB, Olde Rikkert MG, Ahmed AI. Potentially inappropriate prescribing in older patients admitted to psychiatric hospital. Int J Geriatr Psychiatry. 2016;31(2):137–45.CrossRefPubMedGoogle Scholar
  40. 40.
    Hamilton HJ, Gallagher PF, O’Mahony D. Inappropriate prescribing and adverse drug events in older people. BMC Geriatr. 2009;9:5.CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    O’Mahony D, O’Sullivan D, Byrne S, O’Connor MN, Ryan C, Gallagher P. STOPP/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213–8.CrossRefPubMedGoogle Scholar
  42. 42.
    Walker JG, Batterham PJ, Mackinnon AJ, Jorm AF, Hickie I, Fenech M, et al. Oral folic acid and vitamin B-12 supplementation to prevent cognitive decline in community-dwelling older adults with depressive symptoms—the Beyond Ageing Project: a randomized controlled trial. Am J Clin Nutr. 2012;95(1):194–203.CrossRefPubMedGoogle Scholar
  43. 43.
    de Jager CA, Oulhaj A, Jacoby R, Refsum H, Smith AD. Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial. Int J Geriatr Psychiatry. 2012;27(6):592–600.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  • Sophia Hannou
    • 1
  • Pierre Voirol
    • 1
    • 2
  • André Pannatier
    • 1
    • 2
  • Marie-Laure Weibel
    • 1
  • Farshid Sadeghipour
    • 1
    • 2
  • Armin von Gunten
    • 3
  • Jean-Frédéric Mall
    • 3
  • Isabella De Giorgi Salamun
    • 1
  1. 1.PharmacyLausanne University HospitalLausanneSwitzerland
  2. 2.School of Pharmaceutical SciencesGeneva and Lausanne UniversityLausanneSwitzerland
  3. 3.Geriatric Psychiatry ServiceLausanne University HospitalLausanneSwitzerland

Personalised recommendations